# Lexaria Bioscience Corp. (LEXX)

> Source: Nexqual · https://nexqual.com/LEXX · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, Lexaria Bioscience Corp. (LEXX), nexqual.com/LEXX" · informational, not investment advice.

**Price:** USD 2.99 (+6.03% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 2.82 · day 2.74–3.11 · 52w 2.43–21.6 · market cap $6.3M · NCM

## Key facts
- Analysts: None (1 analysts), mean target USD 82.5 (range 82.5–82.5).
- Total return with dividends: 1Y -75.8% vs S&P 500 +18.1%; 5Y -97.1% vs S&P 500 +85.1%.

## Analysts
Consensus None, 1 analysts; mean target USD 82.5 (low 82.5, high 82.5).

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2021-10-11) |
|---|---|---|
| Total return | -75.8% | -97.1% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -76.0% | -50.6% |
| Volatility (annualized) | 134.6% | 118.5% |
| Max drawdown | -86.2% (Dec 2025→Oct 2026) | -97.2% (Oct 2021→Sep 2026) |

## Peers (Biotechnology)
RYTM (Rhythm Pharmaceuticals, Inc.) USD 87.97 +1.57% · BLTE (Belite Bio, Inc) USD 152.62 +0.49% · IOVA (Iovance Biotherapeutics, Inc.) USD 14.72 +1.52% · PRAX (Praxis Precision Medicines, Inc) USD 248.24 +2.01% · IONS (Ionis Pharmaceuticals, Inc.) USD 44.12 +4.11% · SYRE (Spyre Therapeutics, Inc.) USD 80.1 -0.44%

## More
Full page: https://nexqual.com/LEXX · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt